Status:
UNKNOWN
Comparative Immunogenicity Study of Two Hepatitis A Vaccines
Lead Sponsor:
China National Biotec Group Company Limited
Collaborating Sponsors:
Shaanxi Provincial Center for Disease Control and Prevention
Conditions:
Hepatitis A
Eligibility:
All Genders
18-24 years
Phase:
PHASE4
Brief Summary
Hepatitis A is the most prevalent hepatitis which account for approximately 45% . The susceptible population is Children and adolescence, also the morbidity in adult presented rising trend in recent y...
Eligibility Criteria
Inclusion
- The healthy children in mental and physical aged between 18-24 months, and the guardians agree and fully understand the protocol.
- No Hepatitis A disease and contraindication of vaccination
- No history of Hepatitis A Vaccine
- The subjects can follow the requirements of experiment project.
- Do not vaccinate other vaccine in one months.
- Axillary's temperature≤37℃
Exclusion
- Having severe diseases.
- Allergy to the components in Vaccine
- Immune abnormalities
- The people who do not agree with the Inclusion Criteria
- Have a serious chronic disease
- Any conditions which researcher think will influence the results or the subjects.
Key Trial Info
Start Date :
July 26 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 29 2017
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03231605
Start Date
July 26 2017
End Date
December 29 2017
Last Update
August 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanxi Provincial Center for Disease Control and Prevention
Yuncheng, Shanxi, China